Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

A user shared their positive experience with a non-surgical hair replacement system, detailing the purchase and maintenance process, including using Walker Lace Front Support Tape and various adhesives. They found the system secure and undetectable, allowing them to engage in active pursuits without issues.

The conversation discusses hair loss treatments, including minoxidil, finasteride, and dutasteride, with users sharing experiences and side effects. Some users express concerns about side effects like libido issues, while others mention alternative treatments like bee venom and dermarolling.

A user is advocating for Phase 3 trials of the hair loss treatment PP405 to be conducted in Germany, citing benefits like a diverse patient base and faster access for European patients. Despite skepticism about the petition's influence, the user believes it can demonstrate significant interest and potentially influence strategic decisions.

A 22-year-old male is considering switching from topical to oral minoxidil for hair regrowth after experiencing shedding with dutasteride and finasteride. He is also contemplating buzzing his hair to manage the shedding and improve peace of mind.

Clascoterone, a topical anti-androgen, is generating interest for potentially fewer systemic side effects. Users are curious about its effectiveness and details like concentration and duration of use.

Triple Hair Inc. developed a new topical treatment, TH07, combining Finasteride, Latanoprost, and Minoxidil for androgenic alopecia. Users discussed its effectiveness compared to other treatments and shared their own product combinations.

MK-677 (Ibutamoren) helped reduce hair shedding and improved muscle growth for the user. The user advises caution, noting increased appetite and potential weight gain without exercise.

Many users shared their experiences with buzzing their hair while on hair loss treatments like finasteride and minoxidil, with some finding it liberating and others feeling worse. Buzzing makes applying treatments easier, and some users noted improved hair appearance or acceptance of their look.

The conversation discusses hair loss treatment progress 11 weeks after a crown transplant. The user is using minoxidil every two days and biotin daily, without finasteride.

The conversation discusses using scalp massage, balms like Ethera and L'Occitane, and dietary changes such as rosemary tea and tofu to address hair loss. The user is also considering high-intensity interval training and slow breathing to improve hair regrowth.

Verteporfin updates for hair loss and its trials. Users also express interest in exosomes.

The user started using topical latanoprost and dutasteride, experiencing significant hair shedding and scalp itchiness, possibly due to an allergic reaction. They are considering stopping the treatment if the shedding is linked to an allergy.

The conversation discusses the anticipation of clascoterone scalp treatment results for hair loss, with concerns about its availability and high cost. Users express hope for positive outcomes and affordable access.

The conversation discusses hair loss treatments, specifically using finasteride and minoxidil, and emphasizes taking proactive steps rather than blaming external factors. It also touches on the reality of side effects and the importance of trying treatments to find what works.

A new topical treatment called RT1640 claims to reverse AGA using cyclosporine A, Minoxidil, and a new chemical entity, RT175. Users are skeptical due to lack of clinical trial data and inconsistent before-and-after photos.

EdgeLord LLC's RU58841 is discussed for its authenticity and effectiveness in hair loss treatment, with suggestions to dissolve it in Kirkland minoxidil. Users express mixed opinions on the company's legitimacy and product value.

Taking dutasteride with a meal containing fat may improve absorption, but consistency in routine is more important than timing. Minor variations in absorption won't significantly affect efficacy due to dutasteride's long half-life.

People are discussing the group buy and availability of KX-826 for hair loss treatment, with shipments expected around March-April. There is interest in finding more information and joining future group buys.

The conversation is about using micro needling and PTD-DBM for hair loss treatment. The user applies PTD-DBM drops on weekdays and performs micro needling weekly.

The user reported subtle hair regrowth by focusing on scalp health and lifestyle changes, using Nizoral shampoo and methods to reduce inflammation and cortisol, without using finasteride, minoxidil, or other common treatments. Opinions in the conversation varied, with some skeptical of the results and others acknowledging the potential benefits of addressing scalp health and inflammation.

The user experienced decreased sex drive, weaker erections, and brain fog after taking 1mg Finasteride daily for about 2.5 months. They are considering stopping the treatment due to these side effects, and others in the conversation shared similar experiences with Finasteride and Minoxidil.

PP405 is seen as a potential breakthrough for converting vellus hairs to terminal hairs, with users expressing both hope and skepticism. It is compared to treatments like minoxidil and finasteride, with discussions on side effects and marketing concerns.

The user has been taking finasteride, minoxidil, and biotin daily for 7 months and is pleased with the results, avoiding a hair transplant. Another user encourages consistency to maintain progress.

The user shared their positive experience with finasteride for hair loss, noting improved hairline and reduced hair fall without major side effects, except for acne. They expressed concerns about potential facial structure changes but concluded there were none.

ET-02 is seen as promising for addressing hair loss and graying, but PP405 is more advanced in development and has better publicity. Some users plan to use both treatments alongside minoxidil and dutasteride.

Berlin scientists are working on growing hair from adult stem cells. The conversation mentions interest in learning more about the current development of this research.

The conversation discusses the complexity of reversing hair loss and the need for a treatment that specifically targets DHT levels without affecting other bodily functions. It mentions finasteride as a current treatment but highlights the desire for a solution that works solely on the scalp.

A young man faces severe hair loss in his early 20s, using treatments like dutasteride and minoxidil with little success, impacting his self-esteem and relationships. He considers hair systems and therapy as potential solutions.

The conversation discusses the potential for Verteporfin to reduce scarring, making hairline lowering surgeries more viable for men with mild hair loss. The user suggests that if scarring can be minimized, men might opt for hairline lowering instead of using grafts for other areas.

PP405 is a new drug in Phase 2 trials for hair loss, generating cautious optimism among users. Some users are currently using finasteride and experiencing side effects, while others are skeptical about unapproved products being sold.